ECM
UTHR icon

Evergreen Capital Management’s United Therapeutics UTHR Stock Holding History

Evergreen Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.58M Buy
13,992
+872
+7% +$491K 0.13% 157
2026
Q1 		$7.78M Sell
13,120
-468
-3% -$233K 0.17% 138
2025
Q4 		$6.62M Buy
13,588
+633
+5% +$295K 0.15% 149
2025
Q3 		$5.43M Buy
12,955
+194
+2% +$65.2K 0.13% 166
2025
Q2 		$3.67M Buy
12,761
+501
+4% +$150K 0.11% 191
2025
Q1 		$3.78M Buy
12,260
+10,908
+807% +$3.74M 0.13% 184
2024
Q4 		$477K Buy
1,352
+112
+9% +$41.2K 0.02% 530
2024
Q3 		$444K Buy
1,240
+64
+5% +$21.6K 0.01% 551
2024
Q2 		$375K Buy
+1,176
New +$311K 0.01% 569

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Evergreen Capital Management's UTHR Position: Q2 2026 in Review

Evergreen Capital Management increased its United Therapeutics (UTHR) stake by 6.6% in Q2 2026, buying an estimated $491K and bringing the position to 13,992 shares worth $7.58M. The position accounts for 0.13% of the portfolio, ranked #157.

Evergreen Capital Management first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.78M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Evergreen Capital Management held 13,992 shares of United Therapeutics worth $7.58M as of Q2 2026.
  • Evergreen Capital Management bought 872 United Therapeutics shares in Q2 2026, an estimated $491K.
  • United Therapeutics made up 0.13% of Evergreen Capital Management's portfolio in Q2 2026, its #157 holding.
  • Evergreen Capital Management first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Evergreen Capital Management's United Therapeutics position peaked at $7.78M in Q1 2026.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.